Inhibitors of Leucine-Rich Repeat Kinase 2 (LRRK2): Progress and Promise for the Treatment of Parkinson’s Disease

By  

Current Topics in Medicinal Chemistry, Vol. 15, Iss. 10, 2015-05 ,pp. : 927-938

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting leucine-rich repeat kinase 2 in Parkinson's disease

By Chan Sharon L   Angeles Dario C   Tan Eng-King  

Expert Opinion on Therapeutic Targets, Vol. 17, Iss. 12, 2013-12 ,pp. : 1471-1482

Informa Healthcare

Access to resources Recommend Favorite

A new approach to Parkinson's disease: inhibition of leucine-rich repeat kinase-2

By Doggrell Sheila A  

Expert Opinion on Investigational Drugs, Vol. 20, Iss. 4, 2011-04 ,pp. : 587-590

Informa Healthcare

Access to resources Recommend Favorite

Small-molecule BACE1 inhibitors: a patent literature review (2006 – 2011)

By Probst Gary   Xu Ying-zi  

Expert Opinion on Therapeutic Patents, Vol. 22, Iss. 5, 2012-05 ,pp. : 511-540

Informa Healthcare

Access to resources Recommend Favorite

Protein kinase CK2 inhibitors: a patent review

By Cozza Giorgio   Pinna Lorenzo A   Moro Stefano  

Expert Opinion on Therapeutic Patents, Vol. 22, Iss. 9, 2012-09 ,pp. : 1081-1097

Informa Healthcare

Access to resources Recommend Favorite